In spite of advancements in treatment, the high morbidity and mortality rate associated with heart failure are driving the global absorbable antibacterial envelope market. Mortality in patients with heart failure is not only caused by hemodynamic failure, but also by ventricular arrhythmias. The adoption of implantable cardioverter defibrillators (ICDs) to reduce arrhythmic sudden deaths is projected to boost the market ...
Read More »